PIM1 and mesothelioma: Previous evidence has shown that overexpression of PIM1 in various human cancers, such as breast cancer, mesothelioma and glioblastoma9–11, is well correlated with the processes of cancer progression, including cell proliferation, cell cycle arrest, apoptosis, migration, invasion and drug resistance.